You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR VISTIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for VISTIDE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000135 ↗	Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)	Completed	Johns Hopkins Bloomberg School of Public Health	Phase 2/Phase 3	1995-09-01	To evaluate the efficacy and safety of a human anti-CMV monoclonal antibody, MSL-109, as adjunct therapy for controlling CMV retinitis.
NCT00000142 ↗	Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)	Completed	Baylor College of Medicine	Phase 2/Phase 3	1994-04-01	To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗	Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)	Completed	Icahn School of Medicine at Mount Sinai	Phase 2/Phase 3	1994-04-01	To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗	Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)	Completed	Johns Hopkins University	Phase 2/Phase 3	1994-04-01	To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗	Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)	Completed	Louisiana State University Health Sciences Center in New Orleans	Phase 2/Phase 3	1994-04-01	To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗	Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)	Completed	New Jersey Medical School	Phase 2/Phase 3	1994-04-01	To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗	Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)	Completed	New York University School of Medicine	Phase 2/Phase 3	1994-04-01	To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for VISTIDE

Condition Name

Chart
Table

Condition Name for VISTIDE
Intervention	Trials
HIV Infections	4
Cytomegalovirus Retinitis	3
Recurrent Respiratory Papillomatosis	2
Bladder Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for VISTIDE
Intervention	Trials
HIV Infections	4
Cytomegalovirus Retinitis	4
Retinitis	4
Cystitis	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for VISTIDE

Trials by Country

Map
Table

Trials by Country for VISTIDE
Location	Trials
United States	15
France	1
Mexico	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for VISTIDE
Location	Trials
Texas	3
Pennsylvania	1
North Carolina	1
New York	1
New Jersey	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for VISTIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for VISTIDE
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
Phase 2/Phase 3	2
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for VISTIDE
Clinical Trial Phase	Trials
Completed	7
Unknown status	2
Withdrawn	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VISTIDE

Sponsor Name

Chart
Table

Sponsor Name for VISTIDE
Sponsor	Trials
M.D. Anderson Cancer Center	3
Johns Hopkins Bloomberg School of Public Health	3
Gilead Sciences	3
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for VISTIDE
Sponsor	Trials
Other	25
Industry	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.